Aberrant crypt foci

abemaciclib    (uh-BEH-muh-SY-klib)A drug used to treat hormone-receptor positive (HR+), HER2-negative (HER2-) breast cancer that is advanced or has spread to other parts of the body.

Used with aromase inhinitors

It is used with an aromatase inhibitor in postmenopausal women who have not been treated with hormone therapy. It is used with fulvestrant in women whose disease got worse after treatment with hormone therapy. Abemaciclib is also used alone in men and women whose disease got worse after treatment with hormone therapy and previous chemotherapy. It is also being studied in the treatment of other types of cancer. Abemaciclib blocks certain proteins, which may help keep cancer cells from growing.

Cyclin dependent kinase inhibitor

It is a type of cyclin-dependent kinase inhibitor.

Other names

Also called Verzenio.

edit 

WikiMD Resources - Aberrant crypt foci

Latest research (Pubmed)

• Most recent articles
• Most cited
• Ongoing trials

Join WikiMD as a freelancer or paid editor and help improve the page Aberrant crypt foci or others.